Systems-level modeling of cancer-fibroblast interaction

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Wadlow, Raymond C ^a,b,c   Wittner, Ben S ^a,b,c   Finley, S Aidan ^a   Bergquist, Henry ^e   Upadhyay, Rabi ^e   Finn, Stephen ^f   Loda, Massimo ^b,c,f   Mahmood, Umar ^b,e   Ramaswamy, Sridhar ^a,b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVATION; CELL INTERACTION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG FIBROBLAST; MATHEMATICAL MODEL; MELANOMA; MESENCHYME CELL; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SKIN FIBROBLAST; ANIMAL; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; COCULTURE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MESODERM; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PLASMID; THEORETICAL MODEL;

ANIMALS; CELL LINE; COCULTURE TECHNIQUES; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESODERM; MICE; MICE, NUDE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM TRANSPLANTATION; NEOPLASMS; PLASMIDS; TRANSCRIPTION, GENETIC;

EID: 70149111933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006888     Document Type: Article

References (37)

1. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337.
2. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
3. Beppu H, Mwizerwa ON, Beppu Y, Dattwyler MP, Lauwers GY, et al. (2008) Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27: 1063-1070.
4. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
5. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
6. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
7. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, et al. (1991) Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A 88: 6028-6032.
8. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, et al. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65.
9. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98: 12072-12077.
10. Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE, et al. (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254: 255-264.
11. Yashiro M, Ikeda K, Tendo M, Ishikawa T, Hirakawa K (2005) Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells. Breast Cancer Res Treat 90: 307-313.
12. Schmeichel KL, Bissell MJ (2003) Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 116: 2377-2388.
13. Preffer FI, Dombkowski D, Sykes M, Scadden D, Yang YG (2002) Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization. Stem Cells 20: 417-427.
14. Efron B, Tibshirani R (1993) An Introduction to the Bootstrap: Chapman and Hall. 436 p.
15. Venables WN RB (2002) Modern Applied Statistics with S: Springer-Verlag. 495 p.
16. Louwerse DJ, Smilde AK, Kiers HA (1999) Cross-validation of multiway component models. J Chemometrics 13: 491-510.
17. Murase K, Yamazaki Y, Miyazaki S (2004) Deconvolution analysis of dynamic contrast-enhanced data based on singular value decomposition optimized by generalized cross validation. Magn Reson Med Sci 3: 165-175.
18. Nilsson J, de Jong S, Smilde AK (1997) Multiway calibration in 3D QSAR. J Chemometrics 11: 511-524.
19. Sakaie KE, Lowe MJ (2007) An objective method for regularization of fiber orientation distributions derived from diffusion-weighted MRI. Neuroimage 34: 169-176.
20. Wold S (1978) Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models. Technometrics 20: 397-405.
21. Little RJA, Rubin DB (2002) Statistical Analysis With Missing Data. Hoboken, NJ: Wiley & Sons. 381 p.
22. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680.
23. Madsen MW, Briand P (1990) Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines. Eur J Cancer 26: 793-797.
24. Mullen P, Ritchie A, Langdon SP, Miller WR (1996) Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines. Int J Cancer 67: 816-820.
25. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
26. Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, et al. (2003) Expression profiling of epithelial plasticity in tumor progression. Oncogene 22: 7155-7169.
27. Thiery JP, Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18: 31-42.
28. Rowe RG, Li XY, Hu Y, Saunders TL, Virtanen I, et al. (2009) Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol 184: 399-408.
29. Franci C, Takkunen M, Dave N, Alameda F, Gomez S, et al. (2006) Expression of Snail protein in tumor-stroma interface. Oncogene 25: 5134-5144.
30. Affara NI, Andreu P, Coussens LM (2009) Delineating protease functions during cancer development. Methods Mol Biol 539: 1-32.
31. Orend G (2005) Potential oncogenic action of tenascin-C in tumorigenesis. Int J Biochem Cell Biol 37: 1066-1083.
32. De Wever O, Westbroek W, Verloes A, Bloemen N, Bracke M, et al. (2004) Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J Cell Sci 117: 4691-4703.
33. Clark CJ, Sage EH (2008) A prototypic matricellular protein in the tumor microenvironment - where there's SPARC, there's fire. J Cell Biochem 104: 721-732.
34. Mantoni TS, Schendel RR, Rodel F, Niedobitek G, Al-Assar O, et al. (2008) Stromal SPARC expression and patient survival after chemoradiation for nonresectable pancreatic adenocarcinoma. Cancer Biol Ther 7.
35. Ostman A (2004) PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15: 275-286.
36. Hastie T, Tibshirani R, Friedman J (2001) The Elements of Statistical Learning (fig. 14.27): Springer.
37. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.